首页> 外文会议>Laser Florence (Conference) >Percutaneous Diode Laser Disc Nucleoplasty
【24h】

Percutaneous Diode Laser Disc Nucleoplasty

机译:经皮二极管激光圆盘核成形术

获取原文

摘要

The treatment of herniated disc disease (HNP) over the years involved different miniinvasive surgical options. The classical microsurgical approach has been substituted over the years both by endoscopic approach in which is possible to practice via endoscopy a laser thermo-discoplasty, both by percutaneous laser disc nucleoplasty. In the last ten years, the percutaneous laser disc nucleoplasty have been done worldwide in more than 40000 cases of HNP. Because water is the major component of the intervertebral disc, and in HNP pain is caused by the disc protrusion pressing against the nerve root, a 980 nm Diode laser introduced via a 22G needle under X-ray guidance and local anesthesia, vaporizes a small amount of nucleous polposus with a disc shrinkage and a relief of pressure on nerve root. Most patients get off the table pain free and are back to work in 5 to 7 days. Material and method: to date, 130 patients (155 cases) suffering for relevant symptoms therapy-resistant 6 months on average before consulting our department, have been treated. Eightyfour (72%) males and 46 (28%) females had a percutaneous laser disc nucleoplasty. The average age of patients operated was 48 years (22 - 69). The level of disc removal was L3/L4 in 12 cases, L4/L5 in 87 cases and L5/S1 in 56 cases. Two different levels were treated at the same time in 25 patients. Results: the sucess rate at a minimum follow-up of 6 months was 88% with a complication rate of 0.5%.
机译:多年来突出的椎间盘疾病(HNP)的治疗涉及不同的小型外科选择。多年来,经典的显微外科方法通过内窥镜方法来替代,其可以通过内窥镜检查激光​​热磁盘成形术,既通过经皮激光圆盘核成形术。在过去的十年中,经皮激光圆盘骨质成形术已经在全球范围内完成超过40000件HNP。因为水是椎间盘的主要成分,并且在HNP疼痛是由椎间盘突出压迫的椎间盘突出,通过22g针在X射线引导和局部麻醉下引入980nm二极管激光器,蒸发少量核糖丸具有椎间盘收缩和神经根部压力的缓解。大多数患者免费下桌子疼痛,并在5到7天内重新工作。材料和方法:迄今为止,130名患者(155例)患有相关症状治疗抗性6个月,平均咨询我们的部门,得到了治疗。 80Four(72%)男性和46(28%)的女性具有经皮激光圆盘核成形术。运营的患者的平均年龄为48岁(22 - 69)。椎间盘去除水平为L3 / L4,12例,L4 / L5,87例,L5 / S1在56例中。在25名患者中同时治疗了两种不同的水平。结果:最低随访6个月的成功率为88%,并发症率为0.5%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号